Misonix Inc (MSON) Fundamental Analysis & Valuation
NASDAQ:MSON
Current stock price
26.54
+1.2 (+4.74%)
At close:
26.54
0 (0%)
After Hours:
This MSON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. MSON Profitability Analysis
1.1 Basic Checks
- In the past year MSON has reported negative net income.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.28% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | -14.91% | ||
| PM (TTM) | -19.55% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. MSON Health Analysis
2.1 Basic Checks
- There is no outstanding debt for MSON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- MSON has an Altman-Z score of 4.27. This indicates that MSON is financially healthy and has little risk of bankruptcy at the moment.
- A Debt/Equity ratio of 0.29 indicates that MSON is not too dependend on debt financing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.27 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- MSON has a Current Ratio of 2.61. This indicates that MSON is financially healthy and has no problem in meeting its short term obligations.
- A Quick Ratio of 1.92 indicates that MSON should not have too much problems paying its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.61 | ||
| Quick Ratio | 1.92 |
3. MSON Growth Analysis
3.1 Past
- MSON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.00%, which is quite good.
- MSON shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.47%.
- MSON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.21% yearly.
EPS 1Y (TTM)16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48%
Revenue 1Y (TTM)18.47%
Revenue growth 3Y26.37%
Revenue growth 5Y26.21%
Sales Q2Q%43.55%
3.2 Future
- The Earnings Per Share is expected to grow by 6.37% on average over the next years.
- MSON is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.97% yearly.
EPS Next Y10.14%
EPS Next 2Y25.01%
EPS Next 3Y13.04%
EPS Next 5Y6.37%
Revenue Next Year16.14%
Revenue Next 2Y16.55%
Revenue Next 3Y15.78%
Revenue Next 5Y15.97%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. MSON Valuation Analysis
4.1 Price/Earnings Ratio
- MSON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MSON. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -80.24 |
4.3 Compensation for Growth
- MSON's earnings are expected to grow with 13.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.01%
EPS Next 3Y13.04%
5. MSON Dividend Analysis
5.1 Amount
- No dividends for MSON!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MSON Fundamentals: All Metrics, Ratios and Statistics
26.54
+1.2 (+4.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A N/A
Earnings (Next)02-11 2022-02-11/amc
Inst Owners0%
Inst Owner Change-97.67%
Ins Owners7.59%
Ins Owner Change0%
Market Cap462.06M
Revenue(TTM)74.02M
Net Income(TTM)-14.47M
Analysts60
Price Target28.56 (7.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 6.24 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.42 | ||
| P/tB | N/A | ||
| EV/EBITDA | -80.24 |
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.75
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.25
BVpS7.77
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.28% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | -14.91% | ||
| PM (TTM) | -19.55% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.61 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 4.27 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48%
EPS Next Y10.14%
EPS Next 2Y25.01%
EPS Next 3Y13.04%
EPS Next 5Y6.37%
Revenue 1Y (TTM)18.47%
Revenue growth 3Y26.37%
Revenue growth 5Y26.21%
Sales Q2Q%43.55%
Revenue Next Year16.14%
Revenue Next 2Y16.55%
Revenue Next 3Y15.78%
Revenue Next 5Y15.97%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
Misonix Inc / MSON Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for Misonix Inc?
ChartMill assigns a fundamental rating of 4 / 10 to MSON.
What is the valuation status of Misonix Inc (MSON) stock?
ChartMill assigns a valuation rating of 2 / 10 to Misonix Inc (MSON). This can be considered as Overvalued.
What is the profitability of MSON stock?
Misonix Inc (MSON) has a profitability rating of 3 / 10.
Can you provide the financial health for MSON stock?
The financial health rating of Misonix Inc (MSON) is 4 / 10.
How sustainable is the dividend of Misonix Inc (MSON) stock?
The dividend rating of Misonix Inc (MSON) is 0 / 10 and the dividend payout ratio is 0%.